AssetMark Inc
MEDP icon

AssetMark Inc’s Medpace MEDP Stock Holding History

AssetMark Inc’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$74.3K Buy
119
+4
+3% +$2.34K ﹤0.01% 1743
2026
Q2 		$60.9K Sell
115
-3
-3% -$1.38K ﹤0.01% 1770
2026
Q1 		$56.7K Sell
118
-52
-31% -$26.6K ﹤0.01% 1717
2025
Q4 		$95.5K Sell
170
-44
-21% -$25K ﹤0.01% 1506
2025
Q3 		$110K Sell
214
-18
-8% -$7.86K ﹤0.01% 1411
2025
Q2 		$72.8K Buy
232
+16
+7% +$4.8K ﹤0.01% 1440
2025
Q1 		$65.8K Buy
216
+43
+25% +$14.5K ﹤0.01% 1370
2024
Q4 		$57.5K Buy
173
+29
+20% +$9.8K ﹤0.01% 1393
2024
Q3 		$48.1K Sell
144
-43
-23% -$16.3K ﹤0.01% 1299
2024
Q2 		$77K Buy
187
+11
+6% +$4.36K ﹤0.01% 1149
2024
Q1 		$71.1K Sell
176
-44
-20% -$15.5K ﹤0.01% 1100
2023
Q4 		$67.4K Hold
220
– – ﹤0.01% 1101
2023
Q3 		$53.3K Hold
220
– – ﹤0.01% 1084
2023
Q2 		$52.8K Hold
220
– – ﹤0.01% 1059
2023
Q1 		$41.4K Hold
220
– – ﹤0.01% 1075
2022
Q4 		$46.7K Hold
220
– – ﹤0.01% 1057
2022
Q3 		$35K Sell
220
-105
-32% -$16.8K ﹤0.01% 1020
2022
Q2 		$49K Sell
325
-85
-21% -$12.3K ﹤0.01% 918
2022
Q1 		$67K Hold
410
– – ﹤0.01% 860
2021
Q4 		$89K Sell
410
-16
-4% -$3.35K ﹤0.01% 808
2021
Q3 		$81K Hold
426
– – ﹤0.01% 689
2021
Q2 		$75K Buy
426
+10
+2% +$1.73K ﹤0.01% 689
2021
Q1 		$68K Buy
416
+50
+14% +$7.65K ﹤0.01% 685
2020
Q4 		$51K Buy
366
+361
+7,220% +$45.5K ﹤0.01% 710
2020
Q3 		$1K Hold
5
– – ﹤0.01% 1250
2020
Q2 		$0 Sell
5
-2
-29% -$170 ﹤0.01% 1378
2020
Q1 		$1K Sell
7
-24
-77% -$2.08K ﹤0.01% 1273
2019
Q4 		$3K Buy
31
+2
+7% +$155 ﹤0.01% 1185
2019
Q3 		$2K Buy
29
+19
+190% +$1.44K ﹤0.01% 1174
2019
Q2 		$1K Buy
10
+4
+67% +$231 ﹤0.01% 1250
2019
Q1 		$0 Buy
+6
New +$358 ﹤0.01% 1453

Other funds holding MEDP

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.92% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Riverbridge Partners
Riverbridge Partners Minneapolis, Minnesota $3.41B AUM 6.54% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

AssetMark Inc's MEDP Position: Q3 2026 in Review

AssetMark Inc increased its Medpace (MEDP) stake by 3.5% in Q3 2026, buying an estimated $2.34K and bringing the position to 119 shares worth $74.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1743.

AssetMark Inc first reported a position in MEDP in Q1 2019 and has held it in 31 quarters since. The position peaked at $110K in Q3 2025. 369 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • AssetMark Inc held 119 shares of Medpace worth $74.3K as of Q3 2026.
  • AssetMark Inc bought 4 Medpace shares in Q3 2026, an estimated $2.34K.
  • Medpace made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #1743 holding.
  • AssetMark Inc first reported a position in Medpace in Q1 2019 and has held it in 31 quarters since.
  • AssetMark Inc's Medpace position peaked at $110K in Q3 2025.
  • 369 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.